Table 3.
Variable | Studies | Subjects/Events | Adjusted HR (95% CI) |
P |
---|---|---|---|---|
Method of BP measurement | ||||
ABPM*,†,‡,§,║,¶ | 6 | 12610/933 | 1.83 (1.52−2.21) | 0.75 |
HBPM#,**,††,‡‡,§§ | 5 | 17742/394 | 1.75 (1.38−2.20) | |
Mean follow-up length | ||||
≤ 5 years*,¶,#,**,§§ | 5 | 26962/672 | 1.77 (1.41−2.22) | 0.82 |
≥ 5 years†,‡,§,║,††,‡‡ | 6 | 3390/655 | 1.83 (1.49−2.24) | |
Type of composite event | ||||
Stroke + CAD + HF + PR*,†,‡ | 3 | 1791/404 | 1.70 (1.27−2.27) | 0.76 |
Stroke + CAD + HF #,††,‡‡ | 3 | 2000/241 | 2.06 (1.49−2.84) | |
Stroke + CAD║,**,§§ | 3 | 16149/191 | 1.64 (1.16−2.31) | |
All-cause mortality§,¶ | 2 | 10412/491 | 1.85 (1.36−2.51) | |
Ethnicity | ||||
Caucasian only*,†,§,¶,# | 5 | 12586/719 | 1.96 (1.69−2.29) | 0.02 |
Asian only**,§§ | 2 | 15742/153 | 1.38 (1.04−1.83) | |
Black included║,‡‡ | 2 | 700/92 | 2.83 (1.81−4.42) | |
Caucasian, Asian, Hispanic‡,†† | 2 | 1324/363 | 1.58 (1.28−1.96) |
ABPM, ambulatory blood pressure monitoring; CAD, coronary artery disease; CI, confidence interval; HBPM, home blood pressure measurement; HF, heart failure; HR, hazard ratio; PR, peripheral revascularization.
OvA Study;
Chieti-Pescara Study;
IDACO Study;
Hadassah Study;
Jackson Heart Study (included 100% Black patients);
Spanish Registry Study;
SHEAF Study;
J-HEALTH Study;
IDHOCO Study;
Dallas Heart Study (included 50% Black patients);
HONEST Study.